Narrative Review
Recently published articles about Narrative Review
Narrative Review
Incretin Therapies: A New Tool to Combat Metabolic Consequences of Antipsychotic Use
September 4, 2025
Incretin therapies have emerged as a promising treatment option with potential benefits for mitigating cardiometabolic side effects associated with antipsychotics; however, clinical trials have often excluded psychiatric populations.
Narrative Review
Idiopathic Hypersomnia: Recognition and Management in Psychiatric Practice
June 2, 2025
Idiopathic hypersomnia, characterized by excessive daytime sleepiness (EDS), has an estimated population prevalence up to 1.5%. Psychiatric medications may exacerbate EDS and, conversely, idiopathic hypersomnia treatments may exacerbate psychiatric...
Recent JCP Articles on Narrative Review
Commentary
Beyond the Boxed Warning: A Call for Regulation of Psychiatry’s Most Teratogenic Drug
October 6, 2025
The authors assert that while valproate remains invaluable for certain severe conditions, the high risk of teratogenicity means stringent safeguards are needed to regulate its use by individuals capable...